XML 65 R26.htm IDEA: XBRL DOCUMENT v3.20.1
4. Intangible Assets, Goodwill and Other (Tables)
 3 Months Ended
Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes to goodwill by segment

Changes to goodwill by segment were as follows (in millions):
 
Life
Science
 
Clinical
Diagnostics
 
Total
Balances as of December 31, 2019:
 
 
 
 
 
Goodwill
$
250.1

 
$
349.2

 
$
599.3

Accumulated impairment losses
(41.8
)
 
(293.4
)
 
(335.2
)
Goodwill, net
208.3

 
55.8

 
264.1

 
 
 
 
 
 
Acquisitions
—

 
—

 
—

 
 
 
 
 
 
Balances as of March 31, 2020:
 
 
 
 
 
Goodwill
250.1

 
349.2

 
599.3

Accumulated impairment losses
(41.8
)
 
(293.4
)
 
(335.2
)
Goodwill, net
$
208.3

 
$
55.8

 
$
264.1


In conjunction with the purchase of all the issued and outstanding shares of a foreign distributor in October 2019 (see Note 2, "Acquisitions"), we recorded $3.4 million of Customer relationships, a definite-lived intangible assets.
Schedule of identifiable purchased intangible assets with definite lives

Information regarding our identifiable purchased intangible assets with definite and indefinite lives is as follows (in millions):
 
March 31, 2020
 
Weighted-Average Remaining Amortization Period (years)
 
Purchase
Price
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships/lists
6.26
 
$
105.1

 
$
(74.5
)
 
$
30.6

Know how
5.48
 
187.0

 
(162.4
)
 
24.6

Developed product technology
8.14
 
142.1

 
(94.4
)
 
47.7

Licenses
8.51
 
76.0

 
(45.2
)
 
30.8

Tradenames
8.34
 
6.4

 
(3.7
)
 
2.7

Covenants not to compete
5.76
 
3.1

 
(1.4
)
 
1.7

Other
—
 
0.1

 
(0.1
)
 
—

     Total definite-lived intangible assets
 
 
519.8

 
(381.7
)
 
138.1

In-process research and development
 
 
0.2

 
—

 
0.2

     Total purchased intangible assets
 
 
$
520.0

 
$
(381.7
)
 
$
138.3


 
December 31, 2019
 
Weighted-Average Remaining Amortization Period (years)
 
Purchase
Price
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships/lists
6.36
 
$
107.2

 
$
(74.3
)
 
$
32.9

Know how
5.71
 
188.5

 
(162.6
)
 
25.9

Developed product technology
8.31
 
144.2

 
(93.9
)
 
50.3

Licenses
8.74
 
76.0

 
(44.4
)
 
31.6

Tradenames
8.50
 
6.4

 
(3.6
)
 
2.8

Covenants not to compete
6.01
 
3.2

 
(1.4
)
 
1.8

Other
—
 
0.1

 
(0.1
)
 
—

     Total definite-lived intangible assets
 
 
525.6

 
(380.3
)
 
145.3

In-process research and development
 
 
0.2

 
—

 
0.2

     Total purchased intangible assets
 
 
$
525.8

 
$
(380.3
)
 
$
145.5
Finite-lived Intangible Assets Amortization Expense [Table Text Block]

Amortization expense related to purchased intangible assets is as follows (in millions):

 
Three Months Ended
 
March 31,
 
2020
 
2019
 
 
 
 
Amortization expense
$
5.9

 
$
5.5